Study of edaravone dexborneol to prevent seizures after stroke
Part of Brain & nervous system clinical trials.
This study tests if a medicine called edaravone dexborneol, given within 48 hours of a stroke, can lower the risk of developing epilepsy later. It is for people who have had a stroke and are at high risk for post-stroke seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a stroke caused by a blocked blood vessel, confirmed by a brain scan.
- You can start the study medicine within 48 hours of the stroke.
- You have a high risk of post-stroke epilepsy, based on a special score (SeLECT-EEG) of 7 or more.
- You have never had epilepsy or seizures before this stroke.
- You are able to take medicine under your tongue and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is creating a global research database to learn more about seizures that happen after a stroke. By joining, you help doctors better understand who gets these seizures and how to treat them.
This trial tests a new sublingual tablet (Edaravone Dexborneol) to help people recover after a small stroke caused by disease of the small blood vessels in the brain. It aims to see if the drug can improve thinking and daily function.
This trial tests a medicine called edaravone dexborneol to see if it helps people recover from a recent ischemic stroke (a stroke caused by a blocked blood vessel). The medicine is given within 48 hours of the stroke, and the study will compare how well it works and if it is safe.
This trial tests whether a combination of two drugs, edaravone (an antioxidant) and borneol (a natural compound), can improve recovery in people who have had a stroke and also have active cancer. It may help by protecting brain cells and potentially improving motor function.
This study tests an under-the-tongue tablet (edaravone dexborneol) to help thinking and memory problems that can happen after an ischemic stroke. It may help people who recently had a stroke and now have trouble with attention, memory, or planning.
This trial is testing whether a medicine called edaravone can help people who recently had a mild or moderate stroke caused by a blocked blood vessel in the brain. It aims to see if the drug improves recovery when given within the first two days after stroke symptoms start.
Hear when a new Post Stroke Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.